Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)

INTRODUCTION AND BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) has been increasingly recognized as an immune suppressive malignancy. The efficacy of immune checkpoint inhibitors (ICI’s) in the context of recurrent/metastatic (R/M) setting anticipates the possible integration of immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonomo, Pierluigi, Desideri, Isacco, Loi, Mauro, Mangoni, Monica, Sottili, Mariangela, Marrazzo, Livia, Talamonti, Cinzia, Greto, Daniela, Pallotta, Stefania, Livi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862684/
https://www.ncbi.nlm.nih.gov/pubmed/29594250
http://dx.doi.org/10.1016/j.ctro.2018.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862684/
https://www.ncbi.nlm.nih.gov/pubmed/29594250
http://dx.doi.org/10.1016/j.ctro.2018.01.005

Ejemplares similares